Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NAP1L3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | UTP6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | PAFAH1B3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ASCL2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | GOLGA7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ZSWIM4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CBLN1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | MYSM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | MUS81 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | RPL39L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |